Shinobi Therapeutics Funding: $119M Raised, Series A (2024)

Shinobi Therapeutics is based in San Francisco. It has raised $119M in total funding. Latest round: Series A. Backed by Yosemite, Mitsubishi UFJ Capital.

Shinobi Therapeutics funding overview

Shinobi Therapeutics is based in San Francisco. Shinobi Therapeutics has raised $119M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in August 2024. The round record for Shinobi Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Yosemite, Mitsubishi UFJ Capital. 2 distinct backers are named across the disclosed rounds.

Shinobi Therapeutics at a glance

Total raised
$119M
Latest round
Series A
Latest round date
August 2024
Headquarters
San Francisco
Notable investors
Yosemite, Mitsubishi UFJ Capital

Frequently asked about Shinobi Therapeutics funding

How much has Shinobi Therapeutics raised?
Shinobi Therapeutics has raised $119M in total disclosed funding across the rounds on record.
Who has invested in Shinobi Therapeutics?
Yosemite, Mitsubishi UFJ Capital are named among the investors backing Shinobi Therapeutics.
What was the latest Shinobi Therapeutics funding round?
The most recent disclosed round is a Series A, announced in August 2024.
Where is Shinobi Therapeutics based?
Shinobi Therapeutics is based in San Francisco.
When did Shinobi Therapeutics last raise?
The last disclosed Shinobi Therapeutics round closed in August 2024 at Series A.

Round data for Shinobi Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Francisco and backer lists below.

Companies related to Shinobi Therapeutics (21)

Browse related funding lists (6)

Company funding database · Investor directory · Founder database · Mega-rounds 2026